Schwefel, David
Technische Universität Berlin
5 papers on CoChatORCID 0000-0002-2945-0908
Most cited papers
- Verified
HDLBP binds ER-targeted mRNAs by multivalent interactions to promote protein synthesis of transmembrane and secreted proteins
Zinnall, U., Milek, M., Minia, I., Vieira-Vieira, C. H., Müller, S., Mastrobuoni, G., Hazapis, O.-G., Del Giudice, S., Schwefel, D., Bley, N., et al. (2022) · Nature Communications
RNA Research and SplicingRNA and protein synthesis mechanisms
Cited by 30
- Verified
An NADH-controlled gatekeeper of ATP synthase
Schildhauer, F., Ryl, P. S. J., Lauer, S. M., Lenz, S., Barlas, A. B., Ouzounidis, V. R., Jeffrey, K., Marcu, D.-C., O’Reilly, F. J., Graziadei, A., et al. (2025) · Molecular Cell
Mitochondrial Function and PathologyATP Synthase and ATPases Research
Cited by 11
- Verified
Structural mechanism of CRL4‐instructed STAT2 degradation via a novel cytomegaloviral DCAF receptor
Le‐Trilling, V. T. K., Banchenko, S., Paydar, D., Leipe, P. M., Binting, L., Lauer, S., Graziadei, A., Klingen, R., Gotthold, C., Bürger, J., et al. (2023) · The EMBO Journal
interferon and immune responsesCytomegalovirus and herpesvirus research
Cited by 10
- Verified
Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (PROTAC)
Salinas-Rebolledo, C., Blesa, J., Valenzuela-Nieto, G., Schwefel, D., del Rey, N. L. G., Méndez-Ruette, M., Burkhalter, J., Bátiz, L. F., Jara, R., Obeso, J. A., et al. (2024) · eLife
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 3
- Verified
Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (p97-PROTAC)
Salinas-Rebolledo, C., Blesa, J., Valenzuela-Nieto, G., Schwefel, D., López-González del Rey, N., Méndez-Ruette, M., Burkhalter, J., Carrazana, E., Díaz-Tejeda, F., Arias Catalán, I., et al. (2025) · eLife
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free